Hydrogen sulfide is an essential catabolite that intervenes in the pathophysiol. of several diseases from hypertension to stroke, diabetes and pancreatitis. It is endogenously synthesized mainly by two pyridoxal-​5'-​phosphate-​dependent enzymes involved in L-​cysteine metab.: cystathionine-​ss-​synthase (CBS) and cystathionine-​γ-​lyase (CSE)​. Research in this field is currently impaired by the lack of pharmacol. tools such as selective enzymic inhibitors that could target specifically only one of these pathways. We used a novel approach based on a hybrid method that includes drug design, synthetic biol., metabolomics and pharmacol. assays to rationally design a new inhibitor selective for the CSE enzyme. The identification of this compd. opens new frontiers towards a better understanding of the role of CSE over CBS in the pathophysiol. of diseases where a role for the H2S pathway has been proposed and the development of new lead compds. that could target the CSE enzyme.

Fragment-based de novo design of a cystathionine γ-lyase selective inhibitor blocking hydrogen sulfide production / Corvino, Angela; Severino, Beatrice; Fiorino, Ferdinando; Frecentese, Francesco; Magli, Elisa; Perissutti, Elisa; Santagada, Vincenzo; Bucci, Mariarosaria; Cirino, Giuseppe; Kelly, Geoff; Servillo, Luigi; Popowicz, Grzegorz; Pastore, Annalisa; Caliendo, Giuseppe. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 6:34398(2016), pp. 1-11. [10.1038/srep34398]

Fragment-based de novo design of a cystathionine γ-lyase selective inhibitor blocking hydrogen sulfide production

CORVINO, ANGELA;SEVERINO, BEATRICE;FIORINO, FERDINANDO;FRECENTESE, FRANCESCO;MAGLI, ELISA;PERISSUTTI, ELISA;SANTAGADA, VINCENZO;BUCCI, MARIAROSARIA;CIRINO, GIUSEPPE;CALIENDO, GIUSEPPE
2016

Abstract

Hydrogen sulfide is an essential catabolite that intervenes in the pathophysiol. of several diseases from hypertension to stroke, diabetes and pancreatitis. It is endogenously synthesized mainly by two pyridoxal-​5'-​phosphate-​dependent enzymes involved in L-​cysteine metab.: cystathionine-​ss-​synthase (CBS) and cystathionine-​γ-​lyase (CSE)​. Research in this field is currently impaired by the lack of pharmacol. tools such as selective enzymic inhibitors that could target specifically only one of these pathways. We used a novel approach based on a hybrid method that includes drug design, synthetic biol., metabolomics and pharmacol. assays to rationally design a new inhibitor selective for the CSE enzyme. The identification of this compd. opens new frontiers towards a better understanding of the role of CSE over CBS in the pathophysiol. of diseases where a role for the H2S pathway has been proposed and the development of new lead compds. that could target the CSE enzyme.
2016
Fragment-based de novo design of a cystathionine γ-lyase selective inhibitor blocking hydrogen sulfide production / Corvino, Angela; Severino, Beatrice; Fiorino, Ferdinando; Frecentese, Francesco; Magli, Elisa; Perissutti, Elisa; Santagada, Vincenzo; Bucci, Mariarosaria; Cirino, Giuseppe; Kelly, Geoff; Servillo, Luigi; Popowicz, Grzegorz; Pastore, Annalisa; Caliendo, Giuseppe. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 6:34398(2016), pp. 1-11. [10.1038/srep34398]
File in questo prodotto:
File Dimensione Formato  
Scientific Reports, 34398, 2016, 1-11.pdf

solo utenti autorizzati

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 1.35 MB
Formato Adobe PDF
1.35 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/656426
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 18
social impact